Polom Karol, Marrelli Daniele, Smyth Elizabeth C, Voglino Costantino, Roviello Giandomenico, Pascale Valeria, Varas Julian, Vindigni Carla, Roviello Franco
1 University of Siena, Siena, Italy.
2 Medical University of Gdansk, Gdansk, Poland.
Surg Innov. 2018 Apr;25(2):99-104. doi: 10.1177/1553350617751461. Epub 2018 Jan 5.
A positive resection margin (RM+) is acknowledged as a poor prognostic factor after gastrectomy. Microsatellite instability (MSI-H) gastric cancer has been identified as a subgroup of gastric cancer that may be associated with an improved prognosis. The aim of the study was an analysis of MSI status on patients with margin involvement after gastrectomy and examination of the association between MSI, margin status, and survival outcomes.
From a large prospectively annotated surgical database we collected clinicopathological and survival data on patients who had undergone a potentially curative resection for gastric cancer. MSI status was assessed using a standard 5-marker quasi-monomorphic mononucleotide repeat panel. Patients who were R+ and either microsatellite stable (MSS) or MSI-H were identified and clinicopathological characteristics and disease specific survival was compared.
Three hundred and eighty-six patients were identified; 102 (26.4%) cancers were MSI-H. The proportion of R+ resections was not significantly different in MSS and MSI-H groups. For MSS patients 3-, 5-, and 10-year disease-specific survival rates were 9.1%, 0%, and 0%, respectively; for patients with MSI-H R+ tumors these were 38.5%, 30.8%, and 15.4%, respectively. In Cox analysis MSI-H, female gender, and T ≥3 were significantly associated with survival.
Patients with MSI-H gastric cancer may have long-term survival despite R+ margin status. The molecular division of gastric cancer may be an important step in identifying possible tailored surgical treatments corresponding to clinical and pathological factors.
切缘阳性(RM+)被认为是胃癌切除术后预后不良的因素。微卫星不稳定(MSI-H)胃癌已被确定为胃癌的一个亚组,可能与预后改善相关。本研究的目的是分析胃癌切除术后切缘受累患者的MSI状态,并探讨MSI、切缘状态与生存结果之间的关联。
从一个大型前瞻性注释手术数据库中,我们收集了接受胃癌根治性切除患者的临床病理和生存数据。使用标准的5标记准单态单核苷酸重复面板评估MSI状态。识别出R+且微卫星稳定(MSS)或MSI-H的患者,并比较其临床病理特征和疾病特异性生存情况。
共识别出386例患者;102例(26.4%)癌症为MSI-H。MSS组和MSI-H组R+切除的比例无显著差异。对于MSS患者,3年、5年和10年疾病特异性生存率分别为9.1%、0%和0%;对于MSI-H R+肿瘤患者,这些生存率分别为38.5%、30.8%和15.4%。在Cox分析中,MSI-H、女性性别和T≥3与生存显著相关。
尽管切缘状态为R+,MSI-H胃癌患者仍可能长期生存。胃癌的分子分型可能是确定与临床和病理因素相对应的个性化手术治疗方案的重要一步。